- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Oliver Dorigo: Novel Therapies Being Researched by Stanford for Gynecologic Malignancies
Our division at Stanford is very interested in investigating innovative therapies and has a particular focus on immunotherapies, explained Oliver Dorigo, MD, PhD, associate professor, obstetrics and gynecology, Stanford University Medical Center.
Our division at Stanford is very interested in investigating innovative therapies and has a particular focus on immunotherapies, explained Oliver Dorigo, MD, PhD, associate professor, obstetrics and gynecology, Stanford University Medical Center.
Transcript
Are there any novel therapies currently being researched by your division for gynecologic malignancies?
Our division at Stanford in gynecologic oncology is very interested in pushing and investigating very innovative therapies. We have a particular focus on immunotherapies. Immunotherapies can be very diverse. Immune checkpoint inhibitors, as they have been approved, are still being investigated in clinical trials, in particular, in combination with chemotherapy or other immunostimulant drugs.
I’m very excited about cell therapies that allow us to use the body’s own white blood cells, or the patient’s own white blood cells, to potentially create antitumor effects. So, these white blood cells they’re taking out of the patients, they’re potentially genetically modified, so they recognize the tumor. They are then being reinfused, and hopefully recognize the tumor and have antitumor effects.
Community Investment, Engagement Are Essential to Fully Address Cardiovascular Health Disparities
November 19th 2024Community-based researchers can teach clinicians a lot about how to best approach underserved populations disproportionately impacted by cardiovascular health complications.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
